1. Home
  2. LASR vs LRMR Comparison

LASR vs LRMR Comparison

Compare LASR & LRMR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LASR
  • LRMR
  • Stock Information
  • Founded
  • LASR 2000
  • LRMR N/A
  • Country
  • LASR United States
  • LRMR United States
  • Employees
  • LASR N/A
  • LRMR N/A
  • Industry
  • LASR Semiconductors
  • LRMR Biotechnology: Pharmaceutical Preparations
  • Sector
  • LASR Technology
  • LRMR Health Care
  • Exchange
  • LASR Nasdaq
  • LRMR Nasdaq
  • Market Cap
  • LASR 524.6M
  • LRMR 426.9M
  • IPO Year
  • LASR 2018
  • LRMR N/A
  • Fundamental
  • Price
  • LASR $10.26
  • LRMR $6.69
  • Analyst Decision
  • LASR Strong Buy
  • LRMR Strong Buy
  • Analyst Count
  • LASR 3
  • LRMR 8
  • Target Price
  • LASR $16.17
  • LRMR $19.63
  • AVG Volume (30 Days)
  • LASR 521.0K
  • LRMR 743.5K
  • Earning Date
  • LASR 11-07-2024
  • LRMR 10-30-2024
  • Dividend Yield
  • LASR N/A
  • LRMR N/A
  • EPS Growth
  • LASR N/A
  • LRMR N/A
  • EPS
  • LASR N/A
  • LRMR N/A
  • Revenue
  • LASR $203,059,000.00
  • LRMR N/A
  • Revenue This Year
  • LASR $2.20
  • LRMR N/A
  • Revenue Next Year
  • LASR $19.63
  • LRMR N/A
  • P/E Ratio
  • LASR N/A
  • LRMR N/A
  • Revenue Growth
  • LASR N/A
  • LRMR N/A
  • 52 Week Low
  • LASR $9.80
  • LRMR $3.05
  • 52 Week High
  • LASR $15.00
  • LRMR $13.68
  • Technical
  • Relative Strength Index (RSI)
  • LASR 40.73
  • LRMR 39.24
  • Support Level
  • LASR $10.67
  • LRMR $7.20
  • Resistance Level
  • LASR $14.73
  • LRMR $9.50
  • Average True Range (ATR)
  • LASR 0.67
  • LRMR 0.69
  • MACD
  • LASR -0.30
  • LRMR -0.14
  • Stochastic Oscillator
  • LASR 2.30
  • LRMR 5.99

About LASR nLIGHT Inc.

nLight Inc is a United States-based company engaged in providing semiconductor and fiber lasers for industrial, microfabrication, and aerospace and defense applications. It designs, develops and manufactures the critical elements of lasers, through its vertically integrated business model to rapidly introduce innovative products, control costs and protect intellectual property. It operates in two segments: Laser Products, which includes semiconductor lasers, fiber lasers, and directed energy products; and Advanced Development segment includes revenue earned from research and development contracts. The majority of its revenue is generated from the Laser segment. The company's geographical segments include North America, China, and the Rest of the world.

About LRMR Larimar Therapeutics Inc.

Larimar Therapeutics Inc is a clinical-stage biotechnology company focused on developing treatments for patients suffering from complex rare diseases using novel cell-penetrating peptide technology platform. Its lead product candidate, CTI-1601, is a subcutaneously administered, recombinant fusion protein intended to deliver human frataxin (FXN) an essential protein, to the mitochondria of patients with Friedreich's ataxia.

Share on Social Networks: